NewsMarkets

Health

RSV vaccines slash infections in data showing staggering success

New data confirms that RSV vaccines and monoclonal antibody injections are significantly reducing hospitalizations for the respiratory virus.

2 publishers · 3 articles · first seen 9 Nov 2026 · updated 4d ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

2 publishers have covered this in 3 articles since 9 Nov 2026. Quartz published first, on 9 November at 20:33 UTC; Nature followed 51h 27m later. The most recent article, from Nature, appeared on 12 November at 00:00 UTC.

Outlets reporting it: Nature (major outlet), Quartz.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. RSV vaccines slash infections: data show jabs’ staggering success against dangerous virus Nature ·
  2. 10 things to know about RSV in babies, from symptoms to prevention Quartz
  3. 10 ways to tell cold, flu, COVID and RSV symptoms apart Quartz

In this story

  • CDC
Embed this story

Paste this into any web page to show the live odds, with a link back here.